| Jul 10 |
10x Genomics stock slides 14% amid Illumina deal, Deutsche downgrade
|
| Jul 10 |
Illumina (ILMN) Buys Fluent, Grows in Single Cell Research
|
| Jul 10 |
Illumina buys Fluent Biosciences, adding single-cell analysis tech
|
| Jul 9 |
Illumina buys Fluent BioSciences to accelerate single-cell analysis
|
| Jul 9 |
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base
|
| Jul 3 |
The 3 Best Personalized Medicine Stocks to Buy in July 2024
|
| Jun 28 |
Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out
|
| Jun 28 |
Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail
|
| Jun 27 |
Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2
|
| Jun 25 |
Illumina (ILMN) Rises on Conclusion of GRAIL Divestment
|
